journal article·2026-07Open access

A 3D In Vitro Model of the Human Hepatobiliary Junction

Ashley D. Westerfield, Katarzyna A. Grzelak, Katie Katsuyama, Vardhman Kumar, Bess M. Miller, Joa Yun, Jesse Kirkpatrick, David Mankus, Margaret E. Bisher, Abigail K.R. Lytton‐Jean, Z. Gordon Jiang, David D. Lee, Christopher S. Chen, Sangeeta N. Bhatia

Advanced Science· Volume 13· Issue 39

Abstract

ABSTRACT Bile flow is an essential feature of the liver, and disruption of this process contributes to a range of liver pathologies. Efficient bile transport requires coordinated organization between hepatocytes and cholangiocytes at the hepatobiliary junction, a structure that remains poorly captured in existing in vitro models of liver disease. Here, we present a 3D multicellular spheroid‐based model of the human hepatobiliary junction. Building on advances in organoid and spheroid engineering, we co‐aggregate human hepatocytes and intrahepatic cholangiocytes, supported by murine fibroblasts, into adult hepatobiliary organoids (aHBOs). aHBOs directionally transport bile from hepatocyte canaliculi to cholangiocyte‐lined ductule‐like structures, visualized through a high‐throughput imaging assay. Hepatobiliary junction formation and bile flow dynamics are quantified over time using a fluorescent bile acid analog and AI‐assisted image analysis. When subjected to hypoxia‐reoxygenation, aHBOs exhibit disrupted bile transport and distinct cell‐type‐specific responses, enabling interrogation of hepatocyte and cholangiocyte vulnerability to transplant‐associated biliary hypoxia. Our findings suggest a reversible reduction in hepatocyte canalicular function under hypoxia, followed by selective cholangiocyte death upon reoxygenation, potentially contributing to biliary dysfunction after ischemic injury. This human‐derived, scalable platform provides a phenotypically relevant model for dissecting mechanisms of biliary dysfunction and discovering therapeutics for hypoxic liver injury and cholestatic diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Drug Transport and Resistance Mechanisms · Organ Transplantation Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Medical Engineering and Science Massachusetts Institute of Technology Cambridge Massachusetts USA

David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Cambridge Massachusetts USA

Department of Biological Engineering Massachusetts Institute of Technology Cambridge Massachusetts USA

Department of Medicine Brigham and Women's Hospital Boston Massachusetts USA

Department of Medicine Beth Israel Deaconess Medical Center Boston Massachusetts USA

Department of Surgery Beth Israel Deaconess Medical Center Boston Massachusetts USA

Department of Biomedical Engineering and the Biological Design Center Boston University Boston Massachusetts USA

Wyss Institute for Biologically Inspired Engineering at Harvard University Boston Massachusetts USA

Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology Cambridge Massachusetts USA

Funding

National Institute for Academic Anaesthesia · National Science Foundation · National Cancer Institute

References (49)

Show source-provided references
1. 10.1126/scitranslmed.300597510.1126/scitranslmed.3005975 ↗
2. 10.1097/HEP.000000000000126810.1097/HEP.0000000000001268 ↗
3. 10.1002/j.2040-4603.2013.tb00519.x10.1002/j.2040-4603.2013.tb00519.x ↗
4. 10.1016/j.jhep.2015.06.01510.1016/j.jhep.2015.06.015 ↗
5. 10.37349/edd.2022.0000810.37349/edd.2022.00008 ↗
6. 10.1136/jclinpath-2014-20241710.1136/jclinpath-2014-202417 ↗
7. 10.1002/hep.51030061410.1002/hep.510300614 ↗
8. 10.1038/nature1227110.1038/nature12271 ↗
9. 10.1038/s41586-025-08850-110.1038/s41586-025-08850-1 ↗
10. 10.1038/s41586-019-1598-010.1038/s41586-019-1598-0 ↗
11. 10.1016/j.cell.2018.11.01310.1016/j.cell.2018.11.013 ↗
12. 10.1038/s41586-025-08861-y10.1038/s41586-025-08861-y ↗
13. 10.1101/2024.06.10.59826210.1101/2024.06.10.598262 ↗
14. 10.1038/s41596-019-0168-010.1038/s41596-019-0168-0 ↗
15. 10.1038/nbt.327510.1038/nbt.3275 ↗
16. 10.1038/nprot.2016.09710.1038/nprot.2016.097 ↗
17. 10.1038/nature1182610.1038/nature11826 ↗
18. 10.1002/hep.3047010.1002/hep.30470 ↗
19. 10.1002/bit.2754610.1002/bit.27546 ↗
20. 10.1038/s41467-021-23575-110.1038/s41467-021-23575-1 ↗
21. 10.1089/ten.tea.2013.002110.1089/ten.tea.2013.0021 ↗
22. 10.1038/ncomms285310.1038/ncomms2853 ↗
23. 10.1126/scitranslmed.aah550510.1126/scitranslmed.aah5505 ↗
24. 10.1152/ajpgi.00078.202010.1152/ajpgi.00078.2020 ↗
25. 10.1007/s00204-016-1906-510.1007/s00204-016-1906-5 ↗
26. 10.1093/toxsci/kfv15910.1093/toxsci/kfv159 ↗
27. 10.1126/sciadv.adz229910.1126/sciadv.adz2299 ↗
28. 10.1152/ajpgi.00165.202210.1152/ajpgi.00165.2022 ↗
29. 10.1016/j.xpro.2024.10311110.1016/j.xpro.2024.103111 ↗
30. 10.1111/cts.1296910.1111/cts.12969 ↗
31. 10.1155/2012/16432910.1155/2012/164329 ↗
32. 10.1053/j.gastro.2023.02.04110.1053/j.gastro.2023.02.041 ↗
33. 10.1002/lt.2116610.1002/lt.21166 ↗
34. 10.1016/j.ebiom.2022.10443110.1016/j.ebiom.2022.104431 ↗
35. 10.1016/j.jcmgh.2021.10.00910.1016/j.jcmgh.2021.10.009 ↗
36. 10.1016/j.jhep.2012.12.02210.1016/j.jhep.2012.12.022 ↗
37. 10.1016/j.jhep.2008.07.03210.1016/j.jhep.2008.07.032 ↗
38. 10.1038/s41575-019-0125-y10.1038/s41575-019-0125-y ↗
39. 10.1002/adfm.20191044210.1002/adfm.201910442 ↗
40. 10.1089/ten.tea.2013.066710.1089/ten.tea.2013.0667 ↗
41. 10.1038/s41586-025-09183-910.1038/s41586-025-09183-9 ↗
42. Human Assembloids Recapitulate Periportal Liver Tissue In Vitro
43. 10.1038/s41467-025-59639-910.1038/s41467-025-59639-9 ↗
44. 10.1038/s41551-025-01417-510.1038/s41551-025-01417-5 ↗
45. 10.1073/pnas.211586711910.1073/pnas.2115867119 ↗
46. Directing Cholangiocyte Morphogenesis in Natural Biomaterial Scaffolds
47. 10.1001/archinte.159.22.264710.1001/archinte.159.22.2647 ↗
48. 10.1002/hep.3091810.1002/hep.30918 ↗
49. 10.1016/j.celbio.2026.10037810.1016/j.celbio.2026.100378 ↗